|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM122680480 |
003 |
DE-627 |
005 |
20231222195719.0 |
007 |
tu |
008 |
231222s2002 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed24n0409.xml
|
035 |
|
|
|a (DE-627)NLM122680480
|
035 |
|
|
|a (NLM)12483992
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Craig, Maria L
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Visualization of the transfer reaction
|b tracking immune complexes from erythrocyte complement receptor 1 to macrophages
|
264 |
|
1 |
|c 2002
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 03.01.2003
|
500 |
|
|
|a Date Revised 06.11.2019
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Immune complexes (IC) bound to human erythrocytes (E) via complement receptor 1 (CR1) are transferred to phagocytes in the liver and spleen. In an in vitro model system using bispecific mAb reagents (antigen-based heteropolymers) to link IC to E, we have made time-lapse movies in which fluorescently labeled IC cross the E-human macrophage interface and remain associated with the macrophage. Both these movies and fixed-time experiments reveal transfer intermediates in which IC hinge E to macrophages. Examination of model macrophages after transfer indicates that the majority of IC are on the surface at short times (2 min) but are internalized at long times (1-4 h). More than half of the surface IC colocalize with CR1 at 2 min. This evidence supports a model in which CR1-bound IC provide a secure linkage between E and macrophages, allowing rearrangements of the macrophage surface necessary for release of CR1, and IC, from the E
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Research Support, U.S. Gov't, P.H.S.
|
650 |
|
7 |
|a Antibodies, Bispecific
|2 NLM
|
650 |
|
7 |
|a Antigen-Antibody Complex
|2 NLM
|
650 |
|
7 |
|a Immunoglobulin G
|2 NLM
|
650 |
|
7 |
|a Receptors, Complement
|2 NLM
|
650 |
|
7 |
|a Receptors, Complement 3b
|2 NLM
|
650 |
|
7 |
|a Receptors, Fc
|2 NLM
|
650 |
|
7 |
|a DNA
|2 NLM
|
650 |
|
7 |
|a 9007-49-2
|2 NLM
|
700 |
1 |
|
|a Bankovich, Alexander J
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Taylor, Ronald P
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 105(2002), 1 vom: 30. Okt., Seite 36-47
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:105
|g year:2002
|g number:1
|g day:30
|g month:10
|g pages:36-47
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 105
|j 2002
|e 1
|b 30
|c 10
|h 36-47
|